New York, NY (PRWEB) July 10, 2013
Bernstein Liebhard LLP notes that the first federal bellwether trial of a surgical mesh lawsuit involving C.R. Bard transvaginal mesh products began this week in the U.S. District Court, Southern District of West Virginia. According to a report from Bloomberg.com, during yesterday’s opening statements, an attorney for the Plaintiff told a jury of five women and three men that Bard executives knew the company’s Avaulta products had been made from a resin not fit for use in humans, but concealed the flaw from patients and doctors. The Plaintiff, a public health nurse from Georgia, alleges she suffered transvaginal mesh complications after receiving Bard’s Avaulta Plus implant in 2009 to treat pelvic organ prolapse. According to her complaint, the device caused pelvic and rectal pain, bleeding and bladder spasms that have forced her to undergo several surgeries to remove the implant.* (Cisson v. C.R. Bard Inc., 2:11-cv-00195)
“The allegations in this transvaginal mesh lawsuit echo what we have heard from many of our own clients. Our Firm will be monitoring this bellwether trial very closely, as it may provide clues as to how juries will rule in similar cases,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. Firm partner, Jeffery S. Grand, serves on the Plaintiffs Steering Committee in the C.R. Bard litigation underway in the Southern District of West Virginia. Bernstein Liebhard LLP continues to offer free legal consultations to women who allegedly suffered serious transvaginal mesh complications following implantation of devices manufactured by C.R. Bard, Inc., as well as American Medical Systems, Inc., Ethicon, Inc. and Boston Scientific Corp.
Transvaginal Mesh Lawsuits
According to a Case List posted on the Court’s website, more than 3,800 transvaginal mesh lawsuits have been filed against C.R. Bard in the Southern District of West Virginia.
All of the lawsuits allege the use of C.R. Bard’s Avaulta products caused women to suffer a variety of serious complications, including mesh erosion, chronic pain, infections, bleeding, and scarring. (In re C.R. Bard Inc. Pelvic Repair System Products Liability Litigation, MDL No. 2187) Several other multidistrict litigations have also been established in the same federal court for surgical mesh lawsuits pending against other manufacturers, including: In re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2325; In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation - MDL No. 2326; and In re: Ethicon, Inc. Pelvic Repair Systems Products Liability Litigation - MDL No. 2327. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is also serving on the Plaintiffs’ Steering Committee in all of these litigations.
In addition to the cases underway in West Virginia, C.R. Bard has been named a defendant in hundreds of additional transvaginal mesh lawsuits pending in a consolidated proceeding underway in New Jersey’s Atlantic County Superior Court. Mr. Grand is serving as Co-Liaison Counsel in that litigation, and in a second consolidated proceeding underway in Atlantic County for surgical mesh lawsuits involving products manufactured by Ethicon, Inc. He was also a member of the trial team on the first Ethicon trial in that proceeding, which ended in March with an $11 million verdict for the Plaintiff. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)
The U.S. Food & Drug Administration (FDA) is conducting a safety review of pelvic mesh products used to transvaginally treat pelvic organ prolapse and stress urinary incontinence. Since 2008, the agency has issued two Public Health Alerts regarding the risk of serious vaginal mesh complications associated with the device. C.R. Bard and other manufacturers have also been ordered by the agency to conduct safety studies to help the FDA determine how frequently these injuries may occur.**
Alleged victims of serious transvaginal mesh complications may be entitled to compensation for their medical bills, pain and suffering, and other injuries. For more information on filing a transvaginal mesh lawsuit, or to arrange for a free legal consultation, please visit Bernstein Liebhard LLP’s website, or call 800-511-5092.
*bloomberg.com/news/2013-07-09/bard-executives-hid-vaginal-mesh-device-flaw-lawyer-says.html, Bloomberg.com, July 9, 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
# # #
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
Read the full story at http://www.prweb.com/releases/surgical-mesh-lawsuit/mesh-erosion/prweb10915538.htm.
Copyright©2012 Vocus, Inc.
All rights reserved